|
|
News Breaks | | | | December 21, 2012 | | 07:39 EDT |  | WAG | Walgreen adjusts view on FY13 accretion from Alliance Boots investment
The company previously estimated its accretion related to the Alliance Boots investment for FY13 would be 23c-27c per diluted share. As a result of a one-quarter rather than a one-month reporting lag period, the company estimates that the accretion over the last three quarters of FY13 will be an adjusted 25c-29c per diluted share, and an adjusted 18c-22c for the full fiscal year. These estimates do not include amortization expense or one-time transaction costs, and reflect the company’s current estimates of IFRS to GAAP conversion and foreign exchange rates. | |
|
News For WAG From The Last 14 Days Check below for free stories on WAG the last two weeks. |
|
|
| May 17, 2013 | | 12:33 EDT | | WAG | AmerisourceBergen receives approval of Walgreens, Alliance Boots investment
AmerisourceBergen (ABC) announced that the parties have received regulatory approval of the previously disclosed agreement for Walgreen (WAG) and Alliance Boots GmbH to purchase an equity stake in the company. AmerisourceBergen continues to expect the new agreements to contribute an incremental $25B in revenues and approximately 20c in earnings per share in FY14, excluding the amortization of certain expenses related to the transaction and the warrants issued, certain non-recurring costs and a potential LIFO charge, and net of certain start up expenses. In addition, the company reiterated its expectations for financial performance for fiscal year 2013, which includes expected revenue growth in the 11%-13% range, and diluted earnings per share from continuing operations in the lower half of the range of $3.04 to $3.14, excluding certain expenses related to the relationship with Walgreens and Alliance Boots and the warrants issued, and the expected LIFO charge from onboarding of additional branded inventory. | | | May 13, 2013 | | 08:32 EDT | | WAG | Walgreens extends CVS Caremark network provider agreement
 Subscribe for More Information | |
|
|
|
|
|
|
